Cardiomyopathy: Etiology, Types, and Management

1. Dilated Cardiomyopathy

In dilated cardiomyopathy, the heart chambers become enlarged (dilated) and the muscular walls become thin. This leads to significantly reduced contractility, meaning the heart cannot pump enough blood to meet the body's needs. Common causes include myocarditis, certain types of chemotherapy, and genetic conditions like Duchenne muscular dystrophy.

2. Hypertrophic Cardiomyopathy

This type is characterized by the thickening (hypertrophy) of the ventricular walls. While the muscle is "stronger," the thickening can reduce the size of the chambers and may cause an outflow obstruction, where the thickened muscle physically blocks blood from leaving the heart.

3. Restrictive Cardiomyopathy

In restrictive cardiomyopathy, the heart walls become stiff and non-compliant. While the pumping strength (systolic function) might remain relatively normal initially, the stiffness impairs the heart's ability to relax and fill with blood during diastole, leading to diastolic dysfunction.

Clinical Manifestations

Because the symptoms of cardiomyopathy depend on which part of the cardiac cycle is impaired, they vary significantly between patients.

Exam Tip: When assessing a patient with suspected cardiomyopathy, always look for signs of both left-sided failure (like pulmonary congestion/crackles) and right-sided failure (like peripheral edema or hepatomegaly).

Diagnosis and Management

Diagnosis

Clinicians use a combination of tools to diagnose cardiomyopathy and assess its severity:

• History and Physical Exam: Assessing for murmurs, heart sounds, and systemic signs like edema.
• Electrocardiogram (ECG): To identify rhythm disturbances or signs of hypertrophy.
• Echocardiogram: The gold standard for visualizing chamber size, wall thickness, and ejection fraction.
• Cardiac MRI: Provides detailed images of the myocardium.
• Laboratory Tests: To check for biomarkers of heart muscle damage or underlying causes.

Management Strategies

Management is multifaceted, aiming to improve symptoms, prevent complications, and extend life.

Pharmacological Interventions

Medications are the first line of defense to manage heart failure symptoms and stabilize rhythms:

• Diuretics: To reduce fluid volume and decrease preload.
• $\beta$-blockers and ACE Inhibitors: To reduce the workload on the heart and manage blood pressure.
• Anti-arrhythmics or Anticoagulants: Used as needed to manage irregular heartbeats or prevent blood clots.

Advanced Interventions

For patients with high-risk profiles or end-stage disease, more invasive options are required:

• Implantable Cardioverter-Defibrillators (ICDs): These devices are used in high-risk patients to monitor heart rhythms and deliver a shock if life-threatening arrhythmias occur.
• Heart Transplantation: This remains a critical option for patients with end-stage cardiomyopathy who do not respond to other treatments.

Clinical Note: For patients with hypertrophic cardiomyopathy, it is often recommended to avoid competitive sports to reduce the risk of sudden cardiac death.